Rights and permissions
About this article
Cite this article
Pemetrexed + cisplatin benefits worth costs in mesothelioma. Pharmacoecon. Outcomes News 500, 3 (2006). https://doi.org/10.2165/00151234-200605000-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605000-00006